Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma.
Takezawa Y, Izumi K, Shimura Y, Aerken M, Natsagdorji A, Iijima M, Shigehara K, Nohara T, Narimoto K, Kadono Y, Kitagawa Y, Konaka H, Mizokami A.
Takezawa Y, et al. Among authors: iijima m.
Anticancer Res. 2016 Sep;36(9):4961-4. doi: 10.21873/anticanres.11064.
Anticancer Res. 2016.
PMID: 27630356